Publications by authors named "Markus Mandler"

Claim this Profile
W
WISIT vaccines based on IL-31-derived peptides as a novel therapeutic approach for chronic pruritic dermatoses.
Sabine Schmidhuber, James Dickie, Mihály Cserepes, József Tóvári, Achim Schneeberger, Markus Mandler

PLoS One· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improved tropoelastin synthesis in the skin by codon optimization and nucleotide modification of tropoelastin-encoding synthetic mRNA.
Sonia Golombek, Thomas Hoffmann, Ludmilla Hann, Markus Mandler, Sabine Schmidhuber

Mol Ther Nucleic Acids· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Novel C-Type Lectin Receptor-Targeted α-Synuclein-Based Parkinson Vaccine Induces Potent Immune Responses and Therapeutic Efficacy in Mice.
Sabine Schmidhuber, Sandra Scheiblhofer, Richard Weiss, Mihály Cserepes, József Tóvári, Markus Mandler

Vaccines (Basel)· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of mRNA Delivery Modality and Formulation on Cutaneous mRNA Distribution and Downstream eGFP Expression.
Aditya R Darade, Maria Lapteva, Thomas Hoffmann, Markus Mandler, Achim Schneeberger

Pharmaceutics· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of single and combined immunotherapy approach targeting amyloid β protein and α-synuclein in a dementia with Lewy bodies-like model.
Markus Mandler, Edward Rockenstein, Cassia Overk, Michael Mante, Jazmin Florio

Alzheimers Dement· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of modified Interferon alpha mRNA constructs for the treatment of non-melanoma skin cancer.
Sarah Hochmann, Michaela Mittermeir, Radmila Santic, Frieder Koszik, Lanay Griessner, Markus Mandler

Sci Rep· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Active immunization therapies for Parkinson's disease and multiple system atrophy.
Achim Schneeberger, Lanay Tierney, Markus Mandler

Mov Disord· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tailoring the antibody response to aggregated Aß using novel Alzheimer-vaccines.
Markus Mandler, Radmila Santic, Petra Gruber, Yeliz Cinar, Dagmar Pichler

PLoS One· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Next-generation active immunization approach for synucleinopathies: implications for Parkinson's disease clinical trials.
Markus Mandler, Elvira Valera, Edward Rockenstein, Harald Weninger, Christina Patrick

Acta Neuropathol· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Active immunization against complement factor C5a: a new therapeutic approach for Alzheimer's disease.
Christine Landlinger, Lisa Oberleitner, Petra Gruber, Birgit Noiges, Kristyna Yatsyk, Markus Mandler

J Neuroinflammation· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Active immunization against alpha-synuclein ameliorates the degenerative pathology and prevents demyelination in a model of multiple system atrophy.
Markus Mandler, Elvira Valera, Edward Rockenstein, Michael Mante, Harald Weninger

Mol Neurodegener· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pyroglutamylated amyloid-β is associated with hyperphosphorylated tau and severity of Alzheimer's disease.
Markus Mandler, Lauren Walker, Radmila Santic, Peter Hanson, Ajeet Rijal Upadhaya

Acta Neuropathol· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Detection of peri-synaptic amyloid-β pyroglutamate aggregates in early stages of Alzheimer's disease and in AβPP transgenic mice using a novel monoclonal antibody.
Markus Mandler, Edward Rockenstein, Kiren Ubhi, Lawrence Hansen, Anthony Adame

J Alzheimers Dis· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
AFFITOME® technology in neurodegenerative diseases: the doubling advantage.
Achim Schneeberger, Markus Mandler, Frank Mattner, Walter Schmidt

Hum Vaccin· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Limitations of small animal PET imaging with [18F]FDDNP and FDG for quantitative studies in a transgenic mouse model of Alzheimer's disease.
Claudia Kuntner, Adam L Kesner, Martin Bauer, Robert Kremslehner, Thomas Wanek, Markus Mandler

Mol Imaging Biol· October 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FGF signaling is required for initiation of feather placode development.
Markus Mandler, Annette Neubüser

Development· July 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nephric lineage specification by Pax2 and Pax8.
Maxime Bouchard, Abdallah Souabni, Markus Mandler, Annette Neubüser, Meinrad Busslinger

Genes Dev· November 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis